Furthermore, it was demonstrated that HDAC11 promotes breast cancer growth and dissemination from lymph nodes (LNs) through activation of PRM2 (pro-metastatic) and inhibition of E2F7 and E2F8 (cell cycle suppressors) [137]. This evidence concerns the gene HDAC11 and breast cancer.